KWM
ABBV icon

Kingsview Wealth Management’s AbbVie ABBV Stock Holding History

Kingsview Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,100
Closed -$1K – 441
2019
Q2 		$1K Buy
+1,100
New +$86.5K ﹤0.01% 435
2017
Q4 		– Sell
-300
Closed -$1K – 390
2017
Q3 		$1K Buy
+300
New +$22.8K ﹤0.01% 332

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kingsview Wealth Management's ABBV Position: Q1 2026 in Review

Kingsview Wealth Management reduced its AbbVie (ABBV) stake by 0.29% in Q1 2026, selling an estimated $46.8K and leaving 71,619 shares worth $15.6M. The position accounts for 0.21% of the portfolio, ranked #92.

Kingsview Wealth Management first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. The position peaked at $16.4M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Kingsview Wealth Management held 71,619 shares of AbbVie worth $15.6M as of Q1 2026.
  • Kingsview Wealth Management sold 211 AbbVie shares in Q1 2026, an estimated $46.8K.
  • AbbVie made up 0.21% of Kingsview Wealth Management's portfolio in Q1 2026, its #92 holding.
  • Kingsview Wealth Management first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
  • Kingsview Wealth Management's AbbVie position peaked at $16.4M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.